Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogeneous interferon on the antigen-enhanced adoptive transfer of EAE
- PMID: 2579912
- DOI: 10.1159/000233711
Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogeneous interferon on the antigen-enhanced adoptive transfer of EAE
Abstract
The transfer of experimental autoimmune encephalomyelitis (EAE) can be enhanced by incubating lymph node cells (LNC) from EAE rats with myelin basic protein (MBP). Addition of rat fibroblast interferon (RfIFN) to cultures of EAE-LNC just before the addition of MBP, resulted in the inhibition of the adoptive transfer of EAE. Both development of clinical signs, such as weight loss and hind limb paralysis, and histopathological lesions, lymphocytic perivascular infiltrates of the central nervous system, were inhibited by the addition of RfIFN to a final concentration of 300 U/ml or higher. This inhibition was dose dependent and appeared to be mediated primarily by the antiproliferative action of RfIFN.
Similar articles
-
Interferon in experimental autoimmune encephalomyelitis: intraventricular administration.J Interferon Res. 1986 Dec;6(6):627-32. doi: 10.1089/jir.1986.6.627. J Interferon Res. 1986. PMID: 2437223
-
Inhibition of passive localized experimental allergic encephalomyelitis by interferon.Int Arch Allergy Appl Immunol. 1983;72(1):30-3. doi: 10.1159/000234836. Int Arch Allergy Appl Immunol. 1983. PMID: 6192094
-
Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats.Immunology. 1998 Jul;94(3):431-7. doi: 10.1046/j.1365-2567.1998.00526.x. Immunology. 1998. PMID: 9767428 Free PMC article.
-
Suppression of experimental allergic encephalomyelitis by interferon.Immunol Commun. 1982;11(1):1-7. doi: 10.3109/08820138209050718. Immunol Commun. 1982. PMID: 6178681
-
Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.Eur J Immunol. 1995 May;25(5):1391-8. doi: 10.1002/eji.1830250538. Eur J Immunol. 1995. PMID: 7539758
Cited by
-
Interferons in multiple sclerosis. A review of the evidence.Drugs. 1992 Dec;44(6):946-62. doi: 10.2165/00003495-199244060-00004. Drugs. 1992. PMID: 1282865 Review.
-
Mechanisms of action of interferon-beta in multiple sclerosis.Springer Semin Immunopathol. 1996;18(1):125-48. doi: 10.1007/BF00792613. Springer Semin Immunopathol. 1996. PMID: 8984676 Review. No abstract available.
-
Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferonbeta-1b.J Clin Invest. 1997 Aug 1;100(3):604-12. doi: 10.1172/JCI119571. J Clin Invest. 1997. PMID: 9239408 Free PMC article.
-
The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).Agents Actions. 1992 Jan;35(1-2):79-84. doi: 10.1007/BF01990955. Agents Actions. 1992. PMID: 1380765
-
Signaling pathways and therapeutic perspectives related to environmental factors associated with multiple sclerosis.J Neurosci Res. 2018 Dec;96(12):1831-1846. doi: 10.1002/jnr.24322. Epub 2018 Sep 11. J Neurosci Res. 2018. PMID: 30204260 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous